EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
0.4281
-0.0019 (-0.44%)
At close: Oct 22, 2026, 4:00 PM EDT
0.4337
+0.0056 (1.31%)
After-hours: Oct 22, 2026, 7:58 PM EDT
EyePoint Market Cap
EyePoint has a market cap or net worth of $36.91 million as of October 22, 2026. It is the 32,407th most valuable company in the world and the 4,831st biggest in the United States. Its market cap has decreased by 95.47% in one year.
Market Cap
36.91M
Enterprise Value
-121.20M
1-Year Change
-95.47%
Global Rank
Country Rank
#4,831 United States
Category
ChartMarket Cap Chart
Since January 27, 2005, EyePoint's market cap has decreased from $388.60M to $36.91M, a decrease of -90.50%. That is a compound annual growth rate of -10.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 36.90M | -97.56% |
| Dec 31, 2025 | 1.51B | 197.44% |
| Dec 31, 2024 | 508.50M | -37.68% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 39.09M |
| eXoZymes | 38.24M |
| Edesa Biotech | 38.10M |
| NanoViricides | 37.78M |
| Lite Strategy | 36.18M |
| CervoMed | 34.62M |
| Evaxion | 33.78M |
| Filana Therapeutics | 33.26M |